Facioscapulohumeral muscular dystrophy

Alternative Names

Landouzy-Dejerine muscular dystrophy

Definition of Facioscapulohumeral muscular dystrophy

Facioscapulohumeral muscular dystrophy is progressive and loss of muscle tissue.

Causes, incidence, and risk factors

Facioscapulohumeral muscular dystrophy affects the upper body, unlike and , which affect the lower body.

Symptoms

Facioscapulohumeral muscular dystrophy mainly affects the face, shoulder, and upper arm muscles. However, it can affect muscles around the pelvis, hips, and lower leg.

Signs and tests

A physical examination reveals weakness of the facial and shoulder muscles. High blood pressure may be noted but is usually mild. An eye exam may show changes in the blood vessels in the back of the eye.

Treatment

There is no known cure for facioscapulohumeral muscular dystrophy. Treatments are given to control symptoms and improve the person’s quality of life. Activity is encouraged. Inactivity such as bedrest can make the muscle disease worse. Physical therapy may help maintain muscle strength.

Expectations (prognosis)

Disability is often minor. Lifespan is usually not affected.

Review

Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine; Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. – 3/9/2010

Superficial anterior muscles

ADAM Medical Encyclopedia

Article written by

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability.